Kuwaiti firm explores Guyana healthcare and Pharma investments

Guyana’s push to expand healthcare and pharmaceutical capacity is drawing fresh international interest, with Kuwaiti company Royal Group signalling that it is exploring investment opportunities in the local market.

Representatives of the firm met with the Chief Investment Officer and the GO-Invest Agency Head, Peter Ramsaroop, in Georgetown.

The engagement comes as the Government advances plans to deepen local healthcare infrastructure and strengthen the medicines ecosystem. Key priorities include establishing biomedical hubs, upgrading drug supply and distribution systems, and regulatory reforms to improve the availability of medicines, boost health security, and reduce dependence on imported medical supplies.

GO-Invest noted that President Dr. Irfaan Ali, under his Vision 2030 agenda, has repeatedly positioned healthcare and medicine as central to national resilience, higher living standards, and long-term economic diversification.

The administration has also highlighted the need to build domestic capacity not only in the delivery of modern healthcare but also across the full value chain of essential medical inputs, covering supply, storage, and production, supported by updated infrastructure and internationally aligned regulatory standards.

Private sector participation in pharmaceuticals and related healthcare services is expected to complement the Government’s multi-billion-dollar investments in expanded hospital networks, specialised medical services, and efforts to strengthen pharmaceutical manufacturing. Together, these initiatives are intended to strengthen Guyana’s health architecture and move the system toward greater self-sufficiency.

Beyond public health outcomes, the Government has been framing healthcare investment as a development lever, pointing to the potential for skilled employment, technology transfer, and stronger productive capacity. Those spillover effects are considered important to Guyana’s transition to higher-value economic activity over the long term.

Senior Minister in the Office of the President with responsibility for Finance, Dr. Ashni Singh, has also underscored diversification into health-related industries as part of the broader strategy to support balanced growth and sustainability, even as oil and gas continue to drive rapid expansion.

He has stressed that investments that strengthen human capital and social infrastructure are critical to converting economic momentum into durable development.

GO-Invest said engagements of this nature align with Guyana’s approach to attracting responsible international partners whose projects support national priorities and job creation, while advancing resilience across the economy.

Ramsaroop was accompanied by Director of Economic Affairs, Arvinda Ramcharan, and Foreign Service Officer at the Ministry of Foreign Affairs and International Cooperation, Natala Anderson.

Leave a Reply

Your email address will not be published. Required fields are marked *